GlassScriptPhysician profile
Adil K Warsy
NPI 1861470080
$5,942.92
in general payments reported to CMS, 2019-2025
7 companies · $1,668 in 2025
The $1,668 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.11 · 2020: $37.74 · 2021: $15.39 · 2022: $154 · 2023: $4,012 · 2025: $1,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $940 · Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $939.95 |
| Food and Beverage | $240.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,550.26 | 2022-2025 | Ion, Da Vinci Surgical System |
| Olympus Corporation of The Americas | $994.95 | 2023 | Single Use Suction Valve (Sterile), Olympus |
| Astrazeneca Pharmaceuticals LP | $137.04 | 2019-2022 | |
| Abbvie INC. | $125.00 | 2025 | |
| Glaxosmithkline, LLC. | $73.00 | 2019-2025 | |
| Mylan Specialty L.P. | $53.13 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Warsy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.